SCHEMBL19930645

SCHEMBL19930645

CCN(CC)c1cc(-c2ccc(OCC[SiH2]O)c(N)c2)cn(C)c1=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRD4 O60885 12/20 0.52
▸ AURKA O14965 1/20 0.34
▸ TTK P33981 1/20 0.34
▸ AURKB Q96GD4 1/20 0.34
▸ INCENP Q9NQS7 1/20 0.34
▸ RARA P10276 4/20 0.34
▸ RARB P10826 4/20 0.34
▸ RARG P13631 4/20 0.34
▸ GLA P06280 1/20 0.33
▸ CREBBP Q92793 1/20 0.33
▸ BRD9 Q9H8M2 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ MAOA P21397 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ SCN1A P35498 1/20 0.33
▸ KCNH2 Q12809 1/20 0.33
▸ SCN2A Q99250 1/20 0.33
▸ SIGMAR1 Q99720 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16650065 0.67 BRD4 (1.00) BRD4BRD9
SCHEMBL19930836 0.66 BRD4 (0.53) BRD4AURKATTKAURKBINCENP
SCHEMBL21915977 0.66 BRD4 (0.70) BRD4BRD9
SCHEMBL19930732 0.66 BRD4 (0.70) BRD4AURKATTKAURKBINCENP
SCHEMBL25043209 0.62 BRD4 (0.48) BRD4
SCHEMBL19930749 0.61 BRD4 (0.58) BRD4TTK
SCHEMBL19930745 0.59 AURKA (0.50) BRD4AURKATTKAURKBINCENP
SCHEMBL6915411 0.58 BRD4 (0.49) BRD4GLACREBBPCYP1A2CYP2C19
SCHEMBL10426066 0.58 CYP1A2 (0.50) CYP1A2CYP3A4CYP2D6MAOACYP2C19
SCHEMBL19857658 0.57 BRD4 (0.60) BRD4AURKATTKAURKBINCENP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3640241-A1 BROMODOMAIN INHIBITORS Celgene Quanticel Research, Inc. (US) 2020-04-22 — — EP disclosed
EP-3290407-A1 BROMODOMAIN INHIBITORS Celgene Quanticel Research, Inc (US) 2018-03-07 — — EP disclosed
Send feedback